SlideShare a Scribd company logo
CODE OF FEDERAL REGULATIONS
{CFR}IN PHARMACEUTICAL
Presented by
Arabinda Changmai
M.Pharm 1st sem
Assam downtown university
Guided by
Dr. Satyendra Deka
Associate professor
Department of pharmacy
Assam downtown university
Content
 Introduction
 CFR - table of contents
 CFR in pharmaceuticals
 Reference
2
 The Code of Federal Regulations (CFR) is the codification of the general and
permanent rules and regulations published in the Federal Register by the
executive departments and agencies of the federal government of the United
States.
 The CFR annual edition is the codification of the general and permanent rules
published by the Office of the Federal and the Government Publishing Office. In
addition to this annual edition, the CFR is published in an unofficial format
online on the Electronic CFR website, which is updated daily.
3 INTRODUCTION
 The regulations that are published orderly in the Federal Register are
codified and arranged by title, then by chapter (one agency’s regulations) and
finally by subject in the CFR.
 The CFR is divided into 50 titles which represent broad areas subject to
federal regulation. Each title is divided into chapters, subchapters, parts, and
sections.
 A regulation is cited by title, part, and section, e.g. 14 CFR 121.313 (Title
14, Part 121, Section 313).
4
 The soft-cover volumes of the CFR are issued each year in sets on a staggered, quarterly
basis:
Titles 1 – 16 are updated as of January 1
Titles 17 – 27 are updated as of April 1
Titles 29 – 41 are updated as of July 1
Titles 42 – 50 are updated as of October 1
 The color of each set of volumes is changed every year; a current full set may contain
different colored volumes, depending on the time of the year.
 The Office of the Federal Register also keeps an unofficial, online version of the CFR,
the e-CFR, which is normally updated within two days after changes that have been
published in the Federal Register become effective.
5
CFR - Table of Contents
 e - CFR
 Title 1 - General Provisions
 Title 2 - Grants and Agreements
 Title 3 - The President
 Title 4 - Accounts
 Title 5 - Administrative Personnel
 Title 6 - Domestic Security
 Title 7 - Agriculture
6
 Title 8 - Aliens and Nationality
 Title 9 - Animals and Animal Products
 Title 10 - Energy
 Title 11 - Federal Elections
 Title 12 - Banks and Banking
 Title 13 - Business Credit and Assistance
 Title 14 - Aeronautics and Space
 Title 15 - Commerce and Foreign Trade
 Title 16 - Commercial Practices
 Title 17 - Commodity and Securities Exchanges
 Title 18 - Conservation of Power and Water Resources
7
 Title 19 - Customs Duties
 Title 20 - Employees' Benefits
 Title 21 - Food and Drugs
 Title 22 - Foreign Relations
 Title 23 - Highways
 Title 24 - Housing and Urban Development
 Title 25 - Indians
 Title 26 - Internal Revenue
 Title 27 - Alcohol, Tobacco Products and Firearms
 Title 28 - Judicial Administration
 Title 29 - Labor
 Title 30 - Mineral Resources
8
 Title 31 - Money and Finance: Treasury
 Title 32 - National Defense
 Title 33 - Navigation and Navigable Waters
 Title 34 - Education
 Title 35 - Panama Canal [Reserved]
 Title 36 - Parks, Forests, and Public Property
 Title 37 - Patents, Trademarks, and Copyrights
 Title 38 - Pensions, Bonuses, and Veterans' Relief
 Title 39 - Postal Service
 Title 40 - Protection of Environment
 Title 41 - Public Contracts and Property Management
9
 Title 42 - Public Health
 Title 43 - Public Lands: Interior
 Title 44 - Emergency Management and Assistance
 Title 45 - Public Welfare
 Title 46 - Shipping
 Title 47 - Telecommunication
 Title 48 - Federal Acquisition Regulations System
 Title 49 - Transportation
 Title 50 - Wildlife and Fisheries
10
CFR in pharmaceuticals
 Title 21 is the portion of the Code of Federal Regulations that governs food and
drugs within the United States for the Food and Drug Administration (FDA),
the Drug Enforcement Administration (DEA), and the Office of National Drug
Control Policy (ONDCP). It is divided into three chapters:
 Chapter I — Food and Drug Administration
 Chapter II — Drug Enforcement Administration
 Chapter III — Office of National Drug Control Policy
11
Chapter 1
 Most of the Chapter I regulations are based on the Federal Food,
Drug, and Cosmetic Act.
Notable sections:
11 — electronic records and electronic signature related
50 Protection of human subjects in clinical trials
54 Financial Disclosure by Clinical Investigators
56 Institutional Review Boards that oversee clinical trials
58 Good Laboratory Practices (GLP) for nonclinical studies
The 100 series are regulations pertaining to food:
101, especially 101.9 — Nutrition facts label related
(c)(2)(ii) — Requirement to include trans fat values
(c)(8)(iv) — Vitamin and mineral values
106-107 requirements for infant formula
12
110 et seq. cGMPs for food products
111 et seq. cGMPs for Dietary Supplements
170 food additives
190 dietary supplements
The 200 and 300 series are regulations pertaining to pharmaceuticals :
 202-203 Drug advertising and marketing
 210 et seq. cGMPs for pharmaceuticals
 310 et seq. Requirements for new drugs
 328 et seq. Specific requirements for over-the-counter (OTC) drugs.
The 500 series are regulations for animal feeds and animal medications:
 510 et seq. New animal drugs
13
 556 Tolerances for residues of drugs in food animals
The 600 series covers biological products (e.g. vaccines, blood):
 601 Licensing under section 351 of the Public Health Service Act
 606 et seq. cGMPs for human blood and blood products
The 700 series includes the limited regulations on cosmetics:
 701 Labeling requirements
The 800 series are for medical devices:
•803 Medical Device Reporting
•814 Premarket Approval of Medical Devices
•820 et seq. Quality system regulations (analogous to cGMP, but structured
like ISO)
•860 et seq. Listing of specific approved devices and how they are classified
14
The 900 series covers mammography quality requirements enforced
by CDRH.
The 1000 series covers radiation-emitting device (e.g. cell
phones, lasers, x-ray generators); requirements enforced by the Center for
Devices and Radiological Health. It also talks about the FDA citizen petition.
The 1100 series includes updated rules deeming items that statutorily come
under the definition of "tobacco product" to be subject to the Federal Food,
Drug, and Cosmetic Act as amended by the Tobacco Control Act. The items
affected include E-cigarettes, Hookah tobacco, and pipe tobacco.
15
The 1200 series consists of rules primarily based in laws other than the
Food, Drug, and Cosmetic Act:
•1240 Rules promulgated under 361 of the Public Health Service Act on
interstate control of communicable disease, such as:
• Requirements for pasteurization of milk
• Interstate shipment of turtles as pets.
• Interstate shipment of African rodents that may carry monkeypox.
• Sanitation on interstate conveyances (i.e. airplanes and ships)
•1271 Requirements for human cells, tissues, and cellular and tissue-based
products (i.e. the cGTPs).
16
Chapter II
Notable sections:
 1308 — Schedules of controlled substances
1308.03(a) — Administrative Controlled Substances Code Number
1308.11 — List of Schedule I drugs
1308.12 — List of Schedule II drugs
1308.13 — List of Schedule III drugs
1308.14 — List of Schedule IV drugs
1308.15 — List of Schedule V drugs
Chapter III
Notable sections:
 1405 Governmentwide requirements for drug-free workplaces
17
The following regulations apply to the IND application process:
 21CFR Part 50 Protection of Human Subjects
 21CFR Part 54 Financial Disclosure by Clinical Investigators
 21CFR Part 56 Institutional Review Boards
 21CFR Part 58 Good Lab Practice for Nonclinical Laboratory [Animal] Studies
 21CFR Part 201 Drug Labeling
 21CFR Part 312 Investigational New Drug Application
 21CFR Part 314 INDA and NDA Applications for FDA Approval to Market a New Drug
(New Drug Approval)
 21CFR Part 316 Orphan Drugs
18
REFERENCES
 https://en.wikipedia.org/wiki/Title_21_of_the_Code_of_Federal_Regulations
 https://www.gpo.gov/fdsys/granule/CFR-2011-title21-vol4/CFR-2011-title21-vol4-
part211/content-detail.html
 https://www.law.cornell.edu/cfr/text/21/part-211
 https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=211
19

More Related Content

What's hot

The introduction of an orange book
The introduction of an orange bookThe introduction of an orange book
The introduction of an orange book
indus university-icri
 
DMF Drug Master File
DMF   Drug Master FileDMF   Drug Master File
DMF Drug Master File
Rushi Mendhe
 
CTD and eCTD
CTD and eCTDCTD and eCTD
CTD and eCTD
Girish Swami
 
Orange book
Orange bookOrange book
Orange book
Rucha Pathak
 
Generic drugs product development
Generic drugs product developmentGeneric drugs product development
Generic drugs product development
Sachin G
 
Regulatory requirement of EU, MHRA & TGA
Regulatory requirement of EU, MHRA & TGARegulatory requirement of EU, MHRA & TGA
Regulatory requirement of EU, MHRA & TGA
AshwiniBawankule
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and ndaswati2084
 
Drug excipient interaction different method
Drug excipient interaction different methodDrug excipient interaction different method
Drug excipient interaction different method
ROHIT
 
cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]
Akshay Patil
 
Clinical trial protocol development
Clinical trial protocol developmentClinical trial protocol development
Clinical trial protocol development
SACHIN C P
 
Drug excipient interaction
Drug excipient interaction Drug excipient interaction
Drug excipient interaction
DeeptiGupta154
 
THERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRA
THERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRATHERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRA
THERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRA
Manikant Prasad Shah
 
Impd
ImpdImpd
Investigator brochure
Investigator brochureInvestigator brochure
Investigator brochure
kanchangupta66
 
Outsourcing BA and BE to CRO
Outsourcing BA and BE to CROOutsourcing BA and BE to CRO
5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.
Audumbar Mali
 
INVESTIGATOR’S BROCHURE (IB)
 INVESTIGATOR’S BROCHURE (IB) INVESTIGATOR’S BROCHURE (IB)
INVESTIGATOR’S BROCHURE (IB)
SachinFartade
 
Non clinical drug development. ppt
Non clinical drug development. pptNon clinical drug development. ppt
Non clinical drug development. ppt
PRABU12345678
 
Preformulation concept
Preformulation conceptPreformulation concept
Preformulation concept
Bashant Kumar sah
 

What's hot (20)

The introduction of an orange book
The introduction of an orange bookThe introduction of an orange book
The introduction of an orange book
 
DMF Drug Master File
DMF   Drug Master FileDMF   Drug Master File
DMF Drug Master File
 
CTD and eCTD
CTD and eCTDCTD and eCTD
CTD and eCTD
 
Orange book
Orange bookOrange book
Orange book
 
Generic drugs product development
Generic drugs product developmentGeneric drugs product development
Generic drugs product development
 
Regulatory requirement of EU, MHRA & TGA
Regulatory requirement of EU, MHRA & TGARegulatory requirement of EU, MHRA & TGA
Regulatory requirement of EU, MHRA & TGA
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and nda
 
Drug excipient interaction different method
Drug excipient interaction different methodDrug excipient interaction different method
Drug excipient interaction different method
 
cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]
 
Clinical trial protocol development
Clinical trial protocol developmentClinical trial protocol development
Clinical trial protocol development
 
Drug excipient interaction
Drug excipient interaction Drug excipient interaction
Drug excipient interaction
 
Ctd ppt
Ctd pptCtd ppt
Ctd ppt
 
THERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRA
THERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRATHERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRA
THERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRA
 
Impd
ImpdImpd
Impd
 
Investigator brochure
Investigator brochureInvestigator brochure
Investigator brochure
 
Outsourcing BA and BE to CRO
Outsourcing BA and BE to CROOutsourcing BA and BE to CRO
Outsourcing BA and BE to CRO
 
5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.
 
INVESTIGATOR’S BROCHURE (IB)
 INVESTIGATOR’S BROCHURE (IB) INVESTIGATOR’S BROCHURE (IB)
INVESTIGATOR’S BROCHURE (IB)
 
Non clinical drug development. ppt
Non clinical drug development. pptNon clinical drug development. ppt
Non clinical drug development. ppt
 
Preformulation concept
Preformulation conceptPreformulation concept
Preformulation concept
 

Similar to Code of federal regulations {cfr} in pharmaceutical

Code of federal regulatios
Code of federal regulatiosCode of federal regulatios
Code of federal regulatios
IsmailMakanadar
 
Code of Federal Regulations
Code of Federal Regulations Code of Federal Regulations
Code of Federal Regulations
Mohit Angolkar
 
21-CODE CODE OF FEDERAL REGULATIONS (CFR)
21-CODE CODE OF FEDERAL REGULATIONS (CFR) 21-CODE CODE OF FEDERAL REGULATIONS (CFR)
21-CODE CODE OF FEDERAL REGULATIONS (CFR)
surajkumar1499
 
CODE OF FEDERAL REGULATIONS
CODE OF FEDERAL REGULATIONS CODE OF FEDERAL REGULATIONS
CODE OF FEDERAL REGULATIONS
Ankit Malik
 
CFR title 21 parts
CFR title 21 partsCFR title 21 parts
CFR title 21 parts
VENKAT241
 
Cfr ankit
Cfr  ankitCfr  ankit
Cfr ankit
Ankit Malik
 
Code of federal regulations {cfr}
Code of federal regulations {cfr}Code of federal regulations {cfr}
Code of federal regulations {cfr}
Nipun Gupta
 
Usa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augstUsa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augst
RanjiniDM
 
Code of federal regulation by d.j. biswas
Code of federal regulation by d.j. biswasCode of federal regulation by d.j. biswas
Code of federal regulation by d.j. biswas
DIPJYOTI BISWAS
 
LIVING WITH THE EARTHObjectives for this C.docx
LIVING WITH THE EARTHObjectives for this C.docxLIVING WITH THE EARTHObjectives for this C.docx
LIVING WITH THE EARTHObjectives for this C.docx
croysierkathey
 
US FDA Medical Device or Equipment
US FDA Medical Device or EquipmentUS FDA Medical Device or Equipment
US FDA Medical Device or Equipment
DrMohammadKausar
 
Pharma Jurisprudence Schedules & Acts
Pharma Jurisprudence Schedules & ActsPharma Jurisprudence Schedules & Acts
Pharma Jurisprudence Schedules & Acts
NAKUL DHORE
 
January 2016 EHS Regulatory Update
January 2016 EHS Regulatory UpdateJanuary 2016 EHS Regulatory Update
January 2016 EHS Regulatory Update
Doug Huxley
 
Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)
Siddharth Kumar Sahu
 
LIVING WITH THE EARTHCHAPTER 13ENVIRONMENTAL LAWS & COMP.docx
LIVING WITH THE EARTHCHAPTER 13ENVIRONMENTAL LAWS & COMP.docxLIVING WITH THE EARTHCHAPTER 13ENVIRONMENTAL LAWS & COMP.docx
LIVING WITH THE EARTHCHAPTER 13ENVIRONMENTAL LAWS & COMP.docx
croysierkathey
 
List new
List newList new
List new
sourav goswami
 
Drug & Cosmetic Act.pdf
Drug & Cosmetic Act.pdfDrug & Cosmetic Act.pdf
Drug & Cosmetic Act.pdf
PPALIVE
 
USFDA Over View
USFDA  Over ViewUSFDA  Over View
USFDA Over View
Tarif Hussian
 

Similar to Code of federal regulations {cfr} in pharmaceutical (20)

Code of federal regulatios
Code of federal regulatiosCode of federal regulatios
Code of federal regulatios
 
Code of Federal Regulations
Code of Federal Regulations Code of Federal Regulations
Code of Federal Regulations
 
21-CODE CODE OF FEDERAL REGULATIONS (CFR)
21-CODE CODE OF FEDERAL REGULATIONS (CFR) 21-CODE CODE OF FEDERAL REGULATIONS (CFR)
21-CODE CODE OF FEDERAL REGULATIONS (CFR)
 
CODE OF FEDERAL REGULATIONS
CODE OF FEDERAL REGULATIONS CODE OF FEDERAL REGULATIONS
CODE OF FEDERAL REGULATIONS
 
CFR.pptx
CFR.pptxCFR.pptx
CFR.pptx
 
CFR title 21 parts
CFR title 21 partsCFR title 21 parts
CFR title 21 parts
 
Cfr ankit
Cfr  ankitCfr  ankit
Cfr ankit
 
Code of federal regulations {cfr}
Code of federal regulations {cfr}Code of federal regulations {cfr}
Code of federal regulations {cfr}
 
Usa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augstUsa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augst
 
Code of federal regulation by d.j. biswas
Code of federal regulation by d.j. biswasCode of federal regulation by d.j. biswas
Code of federal regulation by d.j. biswas
 
LIVING WITH THE EARTHObjectives for this C.docx
LIVING WITH THE EARTHObjectives for this C.docxLIVING WITH THE EARTHObjectives for this C.docx
LIVING WITH THE EARTHObjectives for this C.docx
 
US FDA Medical Device or Equipment
US FDA Medical Device or EquipmentUS FDA Medical Device or Equipment
US FDA Medical Device or Equipment
 
Pharma Jurisprudence Schedules & Acts
Pharma Jurisprudence Schedules & ActsPharma Jurisprudence Schedules & Acts
Pharma Jurisprudence Schedules & Acts
 
January 2016 EHS Regulatory Update
January 2016 EHS Regulatory UpdateJanuary 2016 EHS Regulatory Update
January 2016 EHS Regulatory Update
 
Irc sec. 280 e memo j
Irc sec. 280 e memo   jIrc sec. 280 e memo   j
Irc sec. 280 e memo j
 
Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)
 
LIVING WITH THE EARTHCHAPTER 13ENVIRONMENTAL LAWS & COMP.docx
LIVING WITH THE EARTHCHAPTER 13ENVIRONMENTAL LAWS & COMP.docxLIVING WITH THE EARTHCHAPTER 13ENVIRONMENTAL LAWS & COMP.docx
LIVING WITH THE EARTHCHAPTER 13ENVIRONMENTAL LAWS & COMP.docx
 
List new
List newList new
List new
 
Drug & Cosmetic Act.pdf
Drug & Cosmetic Act.pdfDrug & Cosmetic Act.pdf
Drug & Cosmetic Act.pdf
 
USFDA Over View
USFDA  Over ViewUSFDA  Over View
USFDA Over View
 

More from Arabinda Changmai

Drug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding siteDrug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding site
Arabinda Changmai
 
Common disease of oral cavity
Common disease of oral cavityCommon disease of oral cavity
Common disease of oral cavity
Arabinda Changmai
 
Phytosome
PhytosomePhytosome
Aquasomes
AquasomesAquasomes
Preformulation stability study
Preformulation stability studyPreformulation stability study
Preformulation stability study
Arabinda Changmai
 
Instrumentation of uv spectroscopy
Instrumentation of uv spectroscopyInstrumentation of uv spectroscopy
Instrumentation of uv spectroscopy
Arabinda Changmai
 

More from Arabinda Changmai (6)

Drug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding siteDrug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding site
 
Common disease of oral cavity
Common disease of oral cavityCommon disease of oral cavity
Common disease of oral cavity
 
Phytosome
PhytosomePhytosome
Phytosome
 
Aquasomes
AquasomesAquasomes
Aquasomes
 
Preformulation stability study
Preformulation stability studyPreformulation stability study
Preformulation stability study
 
Instrumentation of uv spectroscopy
Instrumentation of uv spectroscopyInstrumentation of uv spectroscopy
Instrumentation of uv spectroscopy
 

Recently uploaded

Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
Areesha Ahmad
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SELF-EXPLANATORY
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
University of Maribor
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
kumarmathi863
 
Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
AADYARAJPANDEY1
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
ossaicprecious19
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
sachin783648
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
muralinath2
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
NathanBaughman3
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
Health Advances
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
Scintica Instrumentation
 
Citrus Greening Disease and its Management
Citrus Greening Disease and its ManagementCitrus Greening Disease and its Management
Citrus Greening Disease and its Management
subedisuryaofficial
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
Areesha Ahmad
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
Areesha Ahmad
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Ana Luísa Pinho
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
insect taxonomy importance systematics and classification
insect taxonomy importance systematics and classificationinsect taxonomy importance systematics and classification
insect taxonomy importance systematics and classification
anitaento25
 
in vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptxin vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptx
yusufzako14
 

Recently uploaded (20)

Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
 
Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
 
Citrus Greening Disease and its Management
Citrus Greening Disease and its ManagementCitrus Greening Disease and its Management
Citrus Greening Disease and its Management
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
insect taxonomy importance systematics and classification
insect taxonomy importance systematics and classificationinsect taxonomy importance systematics and classification
insect taxonomy importance systematics and classification
 
in vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptxin vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptx
 

Code of federal regulations {cfr} in pharmaceutical

  • 1. CODE OF FEDERAL REGULATIONS {CFR}IN PHARMACEUTICAL Presented by Arabinda Changmai M.Pharm 1st sem Assam downtown university Guided by Dr. Satyendra Deka Associate professor Department of pharmacy Assam downtown university
  • 2. Content  Introduction  CFR - table of contents  CFR in pharmaceuticals  Reference 2
  • 3.  The Code of Federal Regulations (CFR) is the codification of the general and permanent rules and regulations published in the Federal Register by the executive departments and agencies of the federal government of the United States.  The CFR annual edition is the codification of the general and permanent rules published by the Office of the Federal and the Government Publishing Office. In addition to this annual edition, the CFR is published in an unofficial format online on the Electronic CFR website, which is updated daily. 3 INTRODUCTION
  • 4.  The regulations that are published orderly in the Federal Register are codified and arranged by title, then by chapter (one agency’s regulations) and finally by subject in the CFR.  The CFR is divided into 50 titles which represent broad areas subject to federal regulation. Each title is divided into chapters, subchapters, parts, and sections.  A regulation is cited by title, part, and section, e.g. 14 CFR 121.313 (Title 14, Part 121, Section 313). 4
  • 5.  The soft-cover volumes of the CFR are issued each year in sets on a staggered, quarterly basis: Titles 1 – 16 are updated as of January 1 Titles 17 – 27 are updated as of April 1 Titles 29 – 41 are updated as of July 1 Titles 42 – 50 are updated as of October 1  The color of each set of volumes is changed every year; a current full set may contain different colored volumes, depending on the time of the year.  The Office of the Federal Register also keeps an unofficial, online version of the CFR, the e-CFR, which is normally updated within two days after changes that have been published in the Federal Register become effective. 5
  • 6. CFR - Table of Contents  e - CFR  Title 1 - General Provisions  Title 2 - Grants and Agreements  Title 3 - The President  Title 4 - Accounts  Title 5 - Administrative Personnel  Title 6 - Domestic Security  Title 7 - Agriculture 6
  • 7.  Title 8 - Aliens and Nationality  Title 9 - Animals and Animal Products  Title 10 - Energy  Title 11 - Federal Elections  Title 12 - Banks and Banking  Title 13 - Business Credit and Assistance  Title 14 - Aeronautics and Space  Title 15 - Commerce and Foreign Trade  Title 16 - Commercial Practices  Title 17 - Commodity and Securities Exchanges  Title 18 - Conservation of Power and Water Resources 7
  • 8.  Title 19 - Customs Duties  Title 20 - Employees' Benefits  Title 21 - Food and Drugs  Title 22 - Foreign Relations  Title 23 - Highways  Title 24 - Housing and Urban Development  Title 25 - Indians  Title 26 - Internal Revenue  Title 27 - Alcohol, Tobacco Products and Firearms  Title 28 - Judicial Administration  Title 29 - Labor  Title 30 - Mineral Resources 8
  • 9.  Title 31 - Money and Finance: Treasury  Title 32 - National Defense  Title 33 - Navigation and Navigable Waters  Title 34 - Education  Title 35 - Panama Canal [Reserved]  Title 36 - Parks, Forests, and Public Property  Title 37 - Patents, Trademarks, and Copyrights  Title 38 - Pensions, Bonuses, and Veterans' Relief  Title 39 - Postal Service  Title 40 - Protection of Environment  Title 41 - Public Contracts and Property Management 9
  • 10.  Title 42 - Public Health  Title 43 - Public Lands: Interior  Title 44 - Emergency Management and Assistance  Title 45 - Public Welfare  Title 46 - Shipping  Title 47 - Telecommunication  Title 48 - Federal Acquisition Regulations System  Title 49 - Transportation  Title 50 - Wildlife and Fisheries 10
  • 11. CFR in pharmaceuticals  Title 21 is the portion of the Code of Federal Regulations that governs food and drugs within the United States for the Food and Drug Administration (FDA), the Drug Enforcement Administration (DEA), and the Office of National Drug Control Policy (ONDCP). It is divided into three chapters:  Chapter I — Food and Drug Administration  Chapter II — Drug Enforcement Administration  Chapter III — Office of National Drug Control Policy 11
  • 12. Chapter 1  Most of the Chapter I regulations are based on the Federal Food, Drug, and Cosmetic Act. Notable sections: 11 — electronic records and electronic signature related 50 Protection of human subjects in clinical trials 54 Financial Disclosure by Clinical Investigators 56 Institutional Review Boards that oversee clinical trials 58 Good Laboratory Practices (GLP) for nonclinical studies The 100 series are regulations pertaining to food: 101, especially 101.9 — Nutrition facts label related (c)(2)(ii) — Requirement to include trans fat values (c)(8)(iv) — Vitamin and mineral values 106-107 requirements for infant formula 12
  • 13. 110 et seq. cGMPs for food products 111 et seq. cGMPs for Dietary Supplements 170 food additives 190 dietary supplements The 200 and 300 series are regulations pertaining to pharmaceuticals :  202-203 Drug advertising and marketing  210 et seq. cGMPs for pharmaceuticals  310 et seq. Requirements for new drugs  328 et seq. Specific requirements for over-the-counter (OTC) drugs. The 500 series are regulations for animal feeds and animal medications:  510 et seq. New animal drugs 13
  • 14.  556 Tolerances for residues of drugs in food animals The 600 series covers biological products (e.g. vaccines, blood):  601 Licensing under section 351 of the Public Health Service Act  606 et seq. cGMPs for human blood and blood products The 700 series includes the limited regulations on cosmetics:  701 Labeling requirements The 800 series are for medical devices: •803 Medical Device Reporting •814 Premarket Approval of Medical Devices •820 et seq. Quality system regulations (analogous to cGMP, but structured like ISO) •860 et seq. Listing of specific approved devices and how they are classified 14
  • 15. The 900 series covers mammography quality requirements enforced by CDRH. The 1000 series covers radiation-emitting device (e.g. cell phones, lasers, x-ray generators); requirements enforced by the Center for Devices and Radiological Health. It also talks about the FDA citizen petition. The 1100 series includes updated rules deeming items that statutorily come under the definition of "tobacco product" to be subject to the Federal Food, Drug, and Cosmetic Act as amended by the Tobacco Control Act. The items affected include E-cigarettes, Hookah tobacco, and pipe tobacco. 15
  • 16. The 1200 series consists of rules primarily based in laws other than the Food, Drug, and Cosmetic Act: •1240 Rules promulgated under 361 of the Public Health Service Act on interstate control of communicable disease, such as: • Requirements for pasteurization of milk • Interstate shipment of turtles as pets. • Interstate shipment of African rodents that may carry monkeypox. • Sanitation on interstate conveyances (i.e. airplanes and ships) •1271 Requirements for human cells, tissues, and cellular and tissue-based products (i.e. the cGTPs). 16
  • 17. Chapter II Notable sections:  1308 — Schedules of controlled substances 1308.03(a) — Administrative Controlled Substances Code Number 1308.11 — List of Schedule I drugs 1308.12 — List of Schedule II drugs 1308.13 — List of Schedule III drugs 1308.14 — List of Schedule IV drugs 1308.15 — List of Schedule V drugs Chapter III Notable sections:  1405 Governmentwide requirements for drug-free workplaces 17
  • 18. The following regulations apply to the IND application process:  21CFR Part 50 Protection of Human Subjects  21CFR Part 54 Financial Disclosure by Clinical Investigators  21CFR Part 56 Institutional Review Boards  21CFR Part 58 Good Lab Practice for Nonclinical Laboratory [Animal] Studies  21CFR Part 201 Drug Labeling  21CFR Part 312 Investigational New Drug Application  21CFR Part 314 INDA and NDA Applications for FDA Approval to Market a New Drug (New Drug Approval)  21CFR Part 316 Orphan Drugs 18
  • 19. REFERENCES  https://en.wikipedia.org/wiki/Title_21_of_the_Code_of_Federal_Regulations  https://www.gpo.gov/fdsys/granule/CFR-2011-title21-vol4/CFR-2011-title21-vol4- part211/content-detail.html  https://www.law.cornell.edu/cfr/text/21/part-211  https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=211 19